Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Progression of Cognitive and Physical Symptoms in Multiple Sclerosis

This study is enrolling participants by invitation only.
University of Missouri, Kansas City
Information provided by:
MidAmerica Neuroscience Institute Identifier:
First received: June 16, 2009
Last updated: NA
Last verified: June 2009
History: No changes posted

The purpose of this study is to look at multiple sclerosis patients process of awareness, learning, and judging status over a 3 year time period.

Multiple Sclerosis

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Progression of Cognitive, Affective, and Physical Symptoms in Multiple Sclerosis.

Resource links provided by NLM:

Further study details as provided by MidAmerica Neuroscience Institute:

Estimated Enrollment: 100
Study Start Date: August 2008
Estimated Study Completion Date: August 2013
Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)
Detailed Description:

Patients with multiple sclerosis (MS) frequently experience cognitive and emotional difficulties. Theses neuropsychiatric symptoms are known to be associated with reduced quality of life. However, little is known about the evolution of MS patients' neuropsychiatric difficulties and how these neuropsychiatric changes may be related to other MS symptoms. The purpose of the present study is to examine MS patients' cognitive and emotional status over time as part of standard neuropsychological evaluations in a private practice setting. MS patients presenting for neuropsychological evaluation at the MidAmerica Neuroscience Institute will be provided with the option of participating in thorough evaluation of their cognitive and affective MS symptoms. They will then be followed clinically and receive re-evaluation over a period of 3 years on a yearly basis. It is hoped that this study will help us obtain a better understanding of the factors associated with worsening cognition in MS. A greater understanding of the factors associated with cognitive and affective decline in MS help could lead to the early identification and treatment of at-risk patients.


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Neurology Care Clinic


Inclusion Criteria:

  • Male/female subjects at least 18 years of age with a diagnosis of Clinically Definite Multiple Sclerosis (CDMS) or Clinically Isolated Syndrome (CIS)as confirmed by a neurologist.
  • Subjects must be able to give written informed consent and comply with the study protocol. Subjects must also be able to read, write and understand English.
  • Are capable of performing the requirements of the neuropsychological test battery.

Exclusion Criteria:

  • As judged by the investigator, any clinically significant, unstable or major concomitant disorder or medications.
  • In the opinion of the Investigator should not participate in the study.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00922831

Sponsors and Collaborators
MidAmerica Neuroscience Institute
University of Missouri, Kansas City
Principal Investigator: Hunter T Feaster, PsyD MidAmerica Neuroscience Institute
Principal Investigator: Jared Bruce, PhD University of Missouri, Kansas City
  More Information

No publications provided

Responsible Party: H. Todd Feaster, PsyD, MidAmerica Neuroscience Institute Identifier: NCT00922831     History of Changes
Other Study ID Numbers: 080514
Study First Received: June 16, 2009
Last Updated: June 16, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by MidAmerica Neuroscience Institute:
Cognition, Affective MS symptoms

Additional relevant MeSH terms:
Multiple Sclerosis
Autoimmune Diseases
Autoimmune Diseases of the Nervous System
Demyelinating Autoimmune Diseases, CNS
Demyelinating Diseases
Immune System Diseases
Nervous System Diseases
Pathologic Processes processed this record on November 23, 2014